GPA & MPA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab-related Severe Toxicity | SpringerLink
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
The Risk of Hyperglycaemia with the use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinica
2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis | Reumatología Clínica
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
B-Cell Targeted Therapies: Clinical Trials Update
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management | European Respiratory Society
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
New Drugs for Rheumatoid Arthritis | NEJM
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience | Annals of the Rheumatic Diseases
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar | Immunotherapy
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Internet Scientific Publications
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Biological Therapy for Rheumatoid Arthritis - ppt download
